AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06329739 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Clinical examinations and clinical scales administration
Description: Psychometric assessment of cognitive and behavioral outcomes
Study NCT05209789 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HUGS
Description: Group therapy with the participation of two therapist positively encouraging mother-baby interactions in a non-judgmental manner
Study NCT05209789 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Playtime
Description: Very little intervention from the therapists
Study NCT04804371 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: F18-FDG
Description: Evaluate FDG uptake
Study NCT03439956 — intervention group
Intervention type: PROCEDURE
Intervention: Transvaginal specimen extraction
Description: Previous transvaginal specimen extraction through posterior colpotomy.
Study NCT06222931 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Triplanar vibrating platform
Description: Mechanical vibration emitted by triplanar vibrating platforms
Study NCT06222931 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Side-alternating vibrating platform
Description: Mechanical vibration emitted by side-alternating vibrating platforms
Study NCT06222931 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham vibration
Description: Simulated vibration
Study NCT04652778 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulsed Field Ablation (PFA) using the Centauri System
Description: cardiac ablation using pulsed electric field energy to cause pulmonary vein isolation; cavo-tricuspid isthmus (CTI) line ablation may be performed as needed
Study NCT03917251 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Coronary flow and pressure measurement in patients with ventricular pacing
Description: Coronary flow and pressure measurement in patients with ventricular pacing
Study NCT05568537 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pylarify Piflufolastat Flourine-18 (18F-DCFPyL)
Description: Piflufolastat F18 will first be given intravenously over about 5 seconds.
Study NCT05386394 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active tDCS + Language Therapy
Description: Active tDCS stimulation will be delivered by a battery-driven constant current stimulator. The electrical current will be administered to a pre-specified region of the brain (inferior frontal gyrus). The stimulation will be delivered at an intensity of 2mA (estimated current density 0.04 milliamps (mA)/cm2; estimated total charge 0.048 Coulombs (C)/cm2) in a ramp-like fashion for a maximum of 20 minutes. Language therapy will be conducted in conjunction with stimulation and will target oral and written naming.
Study NCT05386394 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Active tDCS + Language Therapy
Description: Active tDCS stimulation will be delivered by a battery-driven constant current stimulator. The electrical current will be administered to a pre-specified region of the brain (inferior frontal gyrus). The stimulation will be delivered at an intensity of 2mA (estimated current density 0.04 milliamps (mA)/cm2; estimated total charge 0.048 Coulombs (C)/cm2) in a ramp-like fashion for a maximum of 20 minutes. Language therapy will be conducted in conjunction with stimulation and will target oral and written naming.
Study NCT05386394 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham tDCS + Language Therapy
Description: During sham stimulation, current will be administered in a ramp-line fashion but after the ramping the intensity will drop to 0 mA. Language therapy targeting oral and written naming will be administered during sham tDCS stimulation.
Study NCT05386394 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham tDCS + Language Therapy
Description: During sham stimulation, current will be administered in a ramp-line fashion but after the ramping the intensity will drop to 0 mA. Language therapy targeting oral and written naming will be administered during sham tDCS stimulation.
Study NCT05626205 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PARO robot
Description: PARO is an advanced interactive robot. It allows the documented benefits of animal therapy to be administered to patients in environments such as hospitals and extended care facilities where live animals present treatment or logistical difficulties. PARO has five kinds of sensors: tactile, light, audition, temperature, and posture sensors, with which it can perceive people and its environment. PARO can learn to behave in a way that the user prefers, and to respond to its new name.
Study NCT06191029 — intervention group
Intervention type: BEHAVIORAL
Intervention: Urdu translated cognitive failure questionnaire
Description: Urdu Translated version of cognitive failure questionnaire will be given to adults to fill it accordingly and then it's reliability and validity will be checked
Study NCT05697614 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valproic acid
Description: valproic acid is used for general epilepsy type, used in experimental group
Study NCT05697614 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbamazepin
Description: carbamazepine is used for focal type epilepsy, used in experimental group
Study NCT05697614 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenytoin
Description: phenytoin is used for both general or focal epilepsy in case valproic acid or carbamazepine is contraindicated, used in experimental group
Study NCT05697614 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lamotrigine
Description: lamotrigine is used for general epilepsy type, used in control group
Study NCT05697614 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clobazam
Description: clobazam is used for both general or focal epilepsy in case if lamotrigine or oxcarbazepine is not possible to be administered and is used particularly in myoclonic jerk , used in control group
Study NCT05697614 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxcarbazepine
Description: oxcarbazepine is used for focal type epilepsy, used in control group
Study NCT06461000 — intervention group
Intervention type: OTHER
Intervention: Survey
Description: online survey for participants
Study NCT05123430 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Monitoring of the pressure of the middle left atrium
Description: During the MitraClip surgery, additional catheter is installed in order to monitoring the ppressure of the middle left atrium
Study NCT05434169 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Arterial Blood Gas
Description: The procedure of arterial blood collection will be conducted in a seated position for all three groups. The patient is in a supine position, with the forearm comfortably placed on a small table. The needle used for blood collection is a 25 gauge needle without local anesthetic. This method of sampling is identical to the one used in daily practice in the Emergency department of Fribourg
Study NCT05434169 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Arterial Blood Gas
Description: The procedure of arterial blood collection will be conducted in a seated position for all three groups. The patient is in a supine position, with the forearm comfortably placed on a small table. The needle used for blood collection is a 25 gauge needle without local anesthetic. This method of sampling is identical to the one used in daily practice in the Emergency department of Fribourg
Study NCT06333704 — intervention group
Intervention type: BIOLOGICAL
Intervention: SPIKEVAX Bivalent
Description: No study drug will be administered during this study as this is an observational study.
Study NCT06333704 — intervention group
Intervention type: BIOLOGICAL
Intervention: SPIKEVAX X
Description: No study drug will be administered during this study as this is an observational study.
Study NCT05213520 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alternate Day Intermittent Energy Restriction
Description: It is a dietary intervention designed to alternate between full energy consumption on one day and 40% of daily energy requirement on the following day.
Study NCT05213520 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Reduced Calorie Diet
Description: It is a dietary intervention designed to reduce daily calorie intake by 500-1000 kcal below an individual's daily calorie needs.
Study NCT05728268 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dose-dense nab-paclitaxel followed by EC
Description: dose-dense nab-paclitaxel followed by EC
Study NCT05729490 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography
Description: All patients will be subjected to:~Two CT scans (coronary calcium scoring and angiography) using 128 or 160-row scanners with a slice thickness of 0.5 mm (Revolution Evo 128, GE Health care, Chicago, Illinois, USA) or (Aquilion 160, Canon Medical Systems, Tochigi, Japan). Calcium scoring will be performed with the use of prospective electrocardiographic gating with 400-ms gantry rotation, 120-kV tube voltage, and 300-mA tube current. For CTA, retrospective electrocardiographic gating will be used, with heart rate adjusted gantry rotations of 350 ms to 500 ms to enable adaptive multisegmented reconstruction.~Iopromide (Ultravist 370, Bayer AG, Berlin, Germany) is the intravenous contrast medium that will be used for CTA. Beta-blockers will be given if the resting heart rate is 70 beats/min.
Study NCT05209529 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: olaparib
Description: olaparib 300 mg per os BID
Study NCT05209529 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: durvalumab 1500 mg IV Q4 weeks
Study NCT05751421 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zynrelef (Bupivacaine 60 MG / Meloxicam 1.8 MG) Per 2.3 ML Extended Release Solution
Description: zynrelef will be administered during surgery
Study NCT05751421 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine HCl 0.5% Injectable Solution
Description: adductor canal block will be performed using bupivacaine before surgery
Study NCT04191811 — intervention group
Intervention type: BEHAVIORAL
Intervention: Internet-delivered cognitive behavioral therapy for major depressive disorder
Description: Cognitive behavioral therapy delivered over a period of 12 weeks, guided by a psychologist who provides written feedback on home assignments and questions.
Study NCT04191811 — intervention group
Intervention type: BEHAVIORAL
Intervention: Internet-delivered cognitive behavioral therapy for insomnia
Description: Cognitive behavioral therapy delivered over a period of 12 weeks, guided by a psychologist who provides written feedback on home assignments and questions.
Study NCT04191811 — intervention group
Intervention type: BEHAVIORAL
Intervention: Internet-delivered cognitive behavioral therapy for social anxiety disorder
Description: Cognitive behavioral therapy delivered over a period of 12 weeks, guided by a psychologist who provides written feedback on home assignments and questions.
Study NCT06368388 — intervention group
Intervention type: OTHER
Intervention: Prospective data collection
Description: Prospective data collection prior to, during and after phage treatment.
Study NCT05751421 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: primary total knee replacement
Description: primary total knee replacement
Study NCT05751421 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: primary total knee replacement
Description: primary total knee replacement
Study NCT05416840 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clonidine controlled-release patch
Description: Enrolled patients receive clonidine patch (2.5 mg), once a week. The doses are doubled, if the office systolic BP not at goal (\<140 mmHg) at 4 weeks.~All patients receive smoking cessation advice at the beginning, and smoking cessation promotion information is pushed by WeChat three times during the observation period (weeks 2, 4 and 6).
Study NCT05416840 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amlodipine
Description: Enrolled patients receive amlodipine (5 mg), once daily. The doses are doubled, if the office systolic BP not at goal (\<140 mmHg) at 4 weeks.~All patients receive smoking cessation advice at the beginning, and smoking cessation promotion information is pushed by WeChat three times during the observation period (weeks 2, 4 and 6).
Study NCT05107947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biocentric light
Description: Light that changes in intensity and spectral distribution during the day to mimick daylight. High in intensity and high circadian stimulus during daytime and low intensity and low circadian stimulus during late afternoon and night.
Study NCT05085444 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Assigned Interventions CD19/BCMA CAR T-cells
Description: Drug: CD19/BCMA CAR T-cells Each subject receive CD19/BCMA CAR T-cells by intravenous infusion Other Name: CD19/BCMA CAR T-cells injection
Study NCT04748731 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Internet mentalization-based video feedback intervention to improve parental sensitivity in mother-infant dyads with maternal depressive symptoms
Description: a weekly online brief intervention using video-feedback and psycho-educational materials on early parenting
Study NCT04748731 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Psycho-Educational Intervention
Description: Reception of psycho-educational materials
Study NCT04799821 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Participants will be asked to refrain from walnut intake and to follow an isocaloric meal plan that complies with the recommendations of a healthy Mediterranean-style eating pattern.
Study NCT04799821 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walnut intake
Description: Participants will be asked to consume walnuts along with an isocaloric meal plan that complies with the recommendations of a healthy Mediterranean-style eating pattern.
Study NCT06098976 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Water Jet
Description: The water jet works by directing a stream of water towards the gap between your teeth. The stream of water helps to loosen and remove plaque and food particles stuck in this area.
Study NCT06207539 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: hyoscine N-butyl bromide under the generic name of buscopan ampoule produced by Sanofi company
Description: compare between the effects of misoprostol with hyoscine N-butyl bromide and misoprostol alone on shortening the time of abortion induction in the second trimester.
Study NCT06207539 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: misoprostol under the generic name of misotac tablets
Description: compare between the effects of misoprostol with hyoscine N-butyl bromide and misoprostol alone on shortening the time of abortion induction in the second trimester.
Study NCT04995016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: PD-1 inhibitor，Pembrolizumab 200mg IV, every 3 weeks.
Study NCT04995016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Axitinib
Description: Tyrosine kinase inhibitor，licensed for use in treatment of renal cell carcinoma. Oral treatment Axitinib given 5 mg PO BID.
Study NCT05102929 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: active intermittent Theta Burst Stimulation (iTBS)
Description: iTBS is a brief stimulation of a part of the brain with a magnetic field that passes through the scalp and skull safely. It is FDA-approved as a treatment for psychological conditions including depression; however, this device is not approved for the treatment of adults with patients with schizophrenia. This research study is using iTBS off label in SCZ patients to examine research questions.
Study NCT05102929 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: sham intermittent Theta Burst Stimulation (iTBS)
Description: Sham TBS over the left DLPFC will be performed using a Cool-B65 A/P TMS coil, designed to support blinded clinical trials. Specifically, when the coil is placed in the P position (i.e. the placebo position), only a very small amount of current is induced in tissue, thus preventing the activation of cortical neurons.
Study NCT05680584 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melatonin 3 MG
Description: 0.1 mg/ kg melatonin in 10 ml apple juice 1 hour before induction of anesthesia
Study NCT05680584 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydroxyzine Pill
Description: 1 mg/ kg hydroxyzine in 10 ml apple juice 1 hour before induction of anesthesia
Study NCT05680584 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 10 ml apple juice 1 hour before induction of anesthesia
Study NCT06368388 — intervention group
Intervention type: OTHER
Intervention: Prospective data collection
Description: Prospective data collection prior to, during and after standard infection treatment.
Study NCT05509881 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM)
Description: Patients in the CGM arm will undergo continuous real-time unblinded CGM using Dexcom CGM devices.
Study NCT05509881 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Usual care (Self-monitored blood glucose)
Description: Patients in the usual care arm will conduct self-monitored blood glucose at least 4 times/day.
Study NCT06398015 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surgical reconstruction of hip abductor tendon tear
Description: If the patient is allocated to surgical reconstruction, the incision from the sham surgery is continued into the iliotibial band (ITB) and down to the hip abductor tendon complex/greater trochanter. A standardized reconstruction of the HAT with bone anchors is then performed.~This standardized procedure has been used by the surgeons for the last 6 years. The ITB is then closed with looped suture, the subcutaneous tissue sutured with standard resorbable single sutures, the skin stapled and a standard wound dressing is applied.
Study NCT06398015 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham surgery of hip abductor tendon tear
Description: If the patient is allocated to sham surgery, the incision will only include the skin and subcutaneous tissue. Subsequently, the subcutaneous tissue will be sutured with standard resorbable single sutures, the skin stapled and a standard wound dressing applied. The patient will be kept in general anesthesia for 10 minutes after the procedure is finalized to mimic a true intervention (to hinder staff or relatives to comment on the duration of the procedure). The normal standard procedure takes approximately 40 minutes.
Study NCT05469334 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: DeStress for Health Program Participants
Description: Behavioral: DeStress for Health Program The program will consist of 4 in person sessions that are based on empirically supported Positive Psychosocial Well-Being PPWB components including Optimism, Mindfulness, Positive Reprisal as well as Strengths-based Cognitive Behavioral Therapy (SBCBT) to improve behavioral self-regulation towards health-related goals, with an additional class five as a check in that will be used for survey completion. Research staff will conduct face-to-face surveys with participants at baseline and at end of program. Finally, we will conduct a phone-based survey 30 days after program completion to assess sustainability of intervention effects.
Study NCT05820347 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Artificial Intelligence Estimation of Muscle Pressure during Mechanical Ventilation
Description: Estimation of inspiratory muscle pressure by an artificial intelligence algorithm integrated in the mechanical ventilator (FlexiMag, Magnamed, Brazil).
Study NCT05619276 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard serving utensil toolkit
Description: Serving a meal using standard kitchen utensils (100% of subjects experiment with these tools first)
Study NCT05619276 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Optimsed portion-control toolkit
Description: Serving a meal using optimised, portion-control utensils (100% of subjects experiment with these tools second)
Study NCT04713475 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PBGM01
Description: AAVhu68 viral vector
Study NCT04949412 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Vitamin D
Description: serum vitamin D level
Study NCT06449976 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: blue light defocus and blue light filtering
Description: Subjects are asked to watch a terminal display device for 50 minutes, featuring texts and videos with different defocusing treatments. Specifically, they will start by watching text for 5 minutes, followed by 40 minutes of video, and then another 5 minutes of text, totaling a visual task duration of 50 minutes. The participants will complete a total of 4 sets of tests in a random order.
Study NCT05931224 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D064, D702, placebo of D660
Description: Experimental Group Subjects assigned to this group are treated with D064, D702, placebo of D660
Study NCT05931224 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D660, placebo of D064, placebo of D702
Description: Experimental Group Subjects assigned to this group are treated with D660, placebo of D064, placebo of D702
Study NCT05624645 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pelex Upp
Description: Patients were given the Pelex Upp is a non-invasive device that is designed to guide a user through personalized pelvic floor strengthening exercises. Patients used device for four weeks to treat stress urinary incontinence
Study NCT05326035 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: WJ05129
Description: WJ05129:Twice daily (except for single dose), 12 hours apart, fixed time is recommended